Because no one has access to the data in the first part of the Phase III trial, I doubt whether a USA deal will eventuate anytime soon. Would a US company jump in based on a generic recommendation to proceed to the next trial stage? Would they not want to see some hard data?
From what Nina has said about the respective regulatory authorities, I think a China deal is more likely to happen first but who knows how long that would take to organise.
The final readout will be met with great anticipation, but with a very long wait until the final results, I expect the share price to sit quietly for quite a while.
Just my thoughts. As always, I won't turn down unexpected great news.
$2, page-20
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.010(2.50%) |
Mkt cap ! $217.3M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.5¢ | 39.0¢ | $370.0K | 934.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 25531 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 7985 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| DXB (ASX) Chart |